In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Boston Scientific licenses Celsion's BPH technology

Executive Summary

For cash and equity, Celsion (focused heat therapy to treat cancer and other diseases) licensed Boston Scientific exclusive worldwide marketing rights (except for certain Asian and Central and South American countries) to its Microfocus BPH800 Urethroplasty system to treat benign prostatic hyperplasia (BPH). The companies will share sales income.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Alliance
    • Includes Contract
    • Includes Equity
    • R&D and Marketing (Licensing)

Related Companies

UsernamePublicRestriction

Register